Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AVAPRITINIB vs AVATROMBOPAG: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AVAPRITINIB vs AVATROMBOPAG: Safety Overview

Metric AVAPRITINIB AVATROMBOPAG
Total FAERS Reports 10,117 1,813
Deaths Reported 302 114
Death Rate 3.0% 6.3%
Hospitalizations 942 306
Average Patient Age 62.4 yrs 60.8 yrs
% Female Patients 56.5% 60.2%
FDA Approval Date Jan 9, 2020 Jul 24, 2025
Manufacturer Blueprint Medicines Corporation AkaRx, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription